Siren »

Cellebrite Di Ltd Ordinary Shares shares owned by Siren

Quarter-by-quarter ownership of Cellebrite Di Ltd Ordinary Shares (CLBT) shares owned by Siren from 13F filings

Historical chart of Siren investment in Cellebrite Di Ltd Ordinary Shares

Tip: Access up to 7 years of quarterly data

All positions including Cellebrite Di Ltd Ordinary Shares held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellebrite Di Ltd Ordinary Shares by Siren

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.7M 150k 18.04
2025-09-30 $1.7M 90k 18.53
2025-06-30 $960k 60k 16.00

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Olema Pharmaceuticals (OLMA)
Disc Medicine (IRON)
Structure Therapeutics Sponsored Ads (GPCR)
Tango Therapeutics (TNGX)
Arcus Biosciences Incorporated (RCUS)
Stoke Therapeutics (STOK)
Crinetics Pharmaceuticals In (CRNX)

View all positions for Siren

Top funds holding Cellebrite Di Ltd Ordinary Shares

True Wind Capital Management
T. Rowe Price Investment Management
Voss Capital
FMR
Pertento Partners
Invesco
BlackRock
Clal Insurance Enterprises Holdings
Granahan Investment Management
Phoenix Holdings
Renaissance Technologies
Nine Ten Capital Management
Portolan Capital Management
Capital Research Global Investors
Cooper Creek Partners Management

View all funds holding Cellebrite Di Ltd Ordinary Shares